Pneumonitis in Patients Receiving Thoracic Radiotherapy and Osimertinib: A Multi-Institutional Study

202310 citationsJournal Articlegold Open Access

Authors

Leou Ismael Banla

Alice Tzeng · Brigham and Women's Hospital

John P. Baillieul · Brigham and Women's Hospital

Melin J. Kandekhar · Harvard University

Kelly Fitzgerald · Brigham and Women's Hospital

Jaclyn LoPiccolo · Dana-Farber Cancer Institute

Holly A. Poitras · Brigham and Women's Hospital

Abstract

Although the overall rate of pneumonitis in patients receiving TRT and osimertinib was relatively low, there was a small risk of severe toxicity. The mean lung dose was associated with an increased risk of developing pneumonitis. These findings inform decision-making for patients and providers.

Topics & Keywords

Lung Cancer Treatments and Mutations Lung Cancer Diagnosis and Treatment Lung Cancer Research Studies

Publication Details

Published in: JTO Clinical and Research Reports

Volume 4, Issue 10, pp. 100559-100559

DOI: 10.1016/j.jtocrr.2023.100559

Field-Weighted Citation Impact: 2.59

Command Palette

Pneumonitis in Patients Receiving Thoracic Radiotherapy and Osimertinib: A Multi-Institutional Study

Authors

Abstract

Topics & Keywords

Publication Details